MyFinsight
Home
Blog
About
Contact
Download
Download image
Deferred revenue
$4,359,432
Impairment of public
inventory
$4,358,834
Accounts payable
$1,000,257
Depreciation and
amortization expense
$985,242
Provision for doubtful
accounts
$868,795
Losses (gains) on
marketable securities
-$806,267
Compensatory element of stock
options
$417,101
Amortization of operating
lease right-of-use...
$382,876
Prepaid expenses
-$63,837
Inventory
-$56,190
Loss on sale of
property and equipment
-$48,304
Amortization of debt issuance
costs
$20,822
Net cash from
operating activities
$5,478,606
Canceled cashflow
$7,889,351
(decrease) increase in cash
and cash...
-$241,929
Canceled cashflow
$5,478,606
Proceeds from line of
credit
$8,800,000
Proceeds from the
exercise of stock options
$23,101
Sale of marketable
securities
$2,787,907
Sale of property and
equipment
$115,000
Deferred income tax
benefit
-$2,818,688
Net (loss) income
-$2,429,385
Accrued expenses
-$1,531,845
Operating lease liability
-$424,701
Accounts receivable
$405,881
Other current assets
$179,387
Deposits and other
assets, net
$99,464
Net cash used in
financing activities
-$4,745,203
Canceled cashflow
$8,823,101
Net cash used in
investing activities
-$975,332
Canceled cashflow
$2,902,907
Repayment of line of credit
$10,020,000
Dividends paid
$3,231,227
Treasury stock purchases
$169,502
Repayments of note payable
$147,575
Purchases of marketable
securities
$3,647,764
Purchases of property and
equipment
$230,475
Back
Back
Cash Flow
source: myfinsight.com
CRYO CELL INTERNATIONAL INC (CCEL)
CRYO CELL INTERNATIONAL INC (CCEL)